Extracorporeal Photopheresis and Multimodality Immunomodulatory Therapy in the Treatment of Cutaneous T-Cell Lymphoma
β Scribed by StephenK. Richardson; KarenS. McGinnis; Michael Shapiro; MichaelS. Lehrer; EllenJ. Kim; CarmelaC. Vittorio; JacquelineM. Junkins Hopkins; AlainH. Rook
- Book ID
- 106298124
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 91 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1203-4754
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effect of extracorporeal photopheresis (EP) on various cytogenetic parameters has been investigated. During EP the photoactivatable agent 8-methoxypsoralen (8-MOP) was administered orally. After 2 h a leukocyteenriched blood fraction was collected by haemocentrifugation, irradiated with UVA extr
Photopheresis is a pheresis-based therapy that is currently available at approximately 70 medical centers worldwide. Recent evidence indicates that extracorporeal photopheresis can significantly prolong life, as well as induce a 6&750/0 response rate among individuals with advanced cutaneous T-cell